Richard Schilsky to Hematologic Diseases
This is a "connection" page, showing publications Richard Schilsky has written about Hematologic Diseases.
Connection Strength
0.347
-
Update in hematology and oncology: evidence published in 2010. Ann Intern Med. 2011 Apr 05; 154(7):487-94.
Score: 0.334
-
Phase I study of adozelesin administered by 24-hour continuous intravenous infusion. J Natl Cancer Inst. 1994 Mar 02; 86(5):368-72.
Score: 0.006
-
Phase II study of amonafide in gastric adenocarcinoma. An Illinois Cancer Center trial. Invest New Drugs. 1994; 12(3):267-70.
Score: 0.006